BioSpace News Archive

Command Medical Products is pleased to announce Thomas Black as Command Medical Products’ new business development manager.

OncoSec Medical Incorporated announced that it intends to offer and sell shares of its common stock in a public offering.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces presentations at upcoming congresses.

Cancer is the second main reason for deaths in people from all across the world, according to the World Health Organization.

In recent years, there is considerable increase in the number of people living with genetic disorders. This fact has compelled researchers from all across the world to growing their efforts on study of genetics.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces financial results for the three and six months ended June 30, 2020 and provides a corporate update.

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, announced its financial results for the second quarter ended June 30, 2020 and provided an update on recent corporate developments.

Initiated Phase 2b clinical trials of IMR-687 in sickle cell disease and beta-thalassemia; First patient dosed in Ardent Phase 2b sickle cell clinical trial

Bioequivalence study of VAZALORE 325 mg on track with top-line data demonstrating bioequivalence to immediate release aspirin

Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has announced its second quarter financial results for the three and six months ended June 30 , 2020.